| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Loewald
CEO | Chief Executive Officer | 63 | 06/09/2020 |
Matthew Bio
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2022 |
Brian Swierenga
COO | Chief Operating Officer | - | 30/09/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wayne Hewett
CHM | Chairman | 61 | 30/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 2.02B | ||
| -1.64% | +1.16% | +54.09% | +109.07% | 1,043B | ||
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | ||
| -0.05% | +0.98% | +19.08% | +73.55% | 469B | ||
| -0.25% | +0.72% | +33.97% | +45.63% | 355B | ||
| +0.98% | +3.30% | +19.63% | +27.91% | 270B | ||
| -1.91% | +2.59% | +8.09% | +12.53% | 262B | ||
| -1.01% | +8.10% | +41.99% | +51.70% | 222B | ||
| -0.85% | +3.47% | +34.56% | +101.80% | 189B | ||
| -2.53% | -8.57% | -34.17% | -60.67% | 175B | ||
| Average | -0.21% | +1.68% | +25.52% | +47.69% | 403.67B | |
| Weighted average by Cap. | +0.44% | +1.03% | +35.42% | +65.85% |
Employees
-
Sector
Pharmaceuticals
















